Mark R. Hazebroek - Concepedia

Author

Mark R. Hazebroek

Maastricht University Medical Centre ORCID

Also Known As

Hazebroek, M. R., Hazebroek, Mark R., M Hazebroek, M R Hazebroek, M. Hazebroek, M. R. Hazebroek, M.R Hazebroek, M.R. Hazebroek, MARK R. HAZEBROEK, Mark Hazebroek

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Maastricht University Medical Centre Maastricht University KU Leuven Netherlands Heart Institute Instituto de Salud Carlos III

About

Mark R. Hazebroek is an author at Maastricht University Medical Centre specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	685
2	Public Health	4	4	256
3	Engineering	1	1	66
4	Natural Sciences	1	1	88
5	Biochemistry	1	1	88

Mark R. Hazebroek

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure Stéphane Heymans, Maarten F. Corsten, Wouter Verhesen, Circulation	2013	236
MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis Maarten F. Corsten, Anna Papageorgiou, Wouter Verhesen, Circulation Research	2012	217
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy Amrit Lota, Mark R. Hazebroek, Pantazis Theotokis, Circulation	2022	143
Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis Mark R. Hazebroek, Michael J. Kemna, Simon Schalla, International Journal of Cardiology Autoimmune DiseaseVasculitisHematologyImmunologyPathology	2015	140
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial John G.F. Cleland, João Pedro Ferreira, Beatrice Mariottoni, European Heart Journal	2020	137
Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences Job A.J. Verdonschot, Marco Merlo, Fernándo Domínguez, European Heart Journal	2020	116
The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis Maarten F. Corsten, Ward Heggermont, Anna‐Pia Papageorgiou, European Heart Journal	2015	115
Implications of Genetic Testing in Dilated Cardiomyopathy Job A.J. Verdonschot, Mark R. Hazebroek, Ingrid P.C. Krapels, Circulation Genomic and Precision Medicine	2020	113
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy E. Rosalie Witjas‐Paalberends, Nicoletta Piroddi, Kelly Stam, Cardiovascular Research	2013	105
Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy Mark R. Hazebroek, Suzanne Moors, Robert Dennert, Journal of the American College of Cardiology Cardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseMedicine	2015	104

Page 1